These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 8729590)

  • 41. Restenosis after PTCA.
    Assali A; Beigel Y
    Isr J Med Sci; 1995 Jun; 31(6):377-81. PubMed ID: 7607862
    [No Abstract]   [Full Text] [Related]  

  • 42. Low molecular weight heparin in prevention of restenosis after PTCA.
    Preisack MB; Karsch KR
    Thromb Res; 1996; 81(2 Suppl):S53-9. PubMed ID: 8822128
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical practice guidelines for managing dyslipidemias in kidney transplant patients.
    Kasiske BL;
    Am J Transplant; 2005 Jun; 5(6):1576. PubMed ID: 15888073
    [No Abstract]   [Full Text] [Related]  

  • 44. [Statins do not prevent restenosis after coronary angioplasty: where to go from here?].
    Horlitz M; Sigwart U; Niebauer J
    Herz; 2001 Mar; 26(2):119-28. PubMed ID: 11349614
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Revascularization of coronary atherosclerosis in patients with diabetes mellitus--there is more to it than meets the image intensifier.
    Petersen JL; Harrington RA
    Am Heart J; 2005 Feb; 149(2):190-3. PubMed ID: 15846254
    [No Abstract]   [Full Text] [Related]  

  • 46. Fluvastatin reduces the high mobility group box 1 protein expression in hyperlipidemia.
    Haraba R; Uyy E; Suica VI; Ivan L; Antohe F
    Int J Cardiol; 2011 Jul; 150(1):105-7. PubMed ID: 21565414
    [No Abstract]   [Full Text] [Related]  

  • 47. Healing unhealthy Hungarian hearts--at what cost?--With what benefit?
    Szucs TD
    Cardiovasc Drugs Ther; 2006 Aug; 20(4):239-43. PubMed ID: 17019538
    [No Abstract]   [Full Text] [Related]  

  • 48. Suppression of neointimal hyperplasia following angioplasty-induced vascular injury in pigs infected with swinepox virus.
    Shimamura T; Jeng D; Lucas A; Essani K
    Open Virol J; 2012; 6():91-6. PubMed ID: 23136622
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Pathology is capable of providing more scientific basis for further improving the prevention and treatment of coronary heart disease].
    She M
    Zhonghua Bing Li Xue Za Zhi; 1998 Jun; 27(3):165-7. PubMed ID: 11244972
    [No Abstract]   [Full Text] [Related]  

  • 50. Use of fish oil to prevent coronary angioplasty restenosis.
    Mauro VF; Frazee LA
    Ann Pharmacother; 1992 Dec; 26(12):1541-5. PubMed ID: 1482813
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Hyperlipidemic Subject with Multiple Risk Factors: A Comprehensive Approach. Proceedings of a symposium. Jerusalem, Israel, September 5, 1993.
    Am J Med; 1994 Jun; 96(6A):1S-93S. PubMed ID: 7912474
    [No Abstract]   [Full Text] [Related]  

  • 52. Mechanisms of restenosis.
    Casscells W; Engler D; Willerson JT
    Tex Heart Inst J; 1994; 21(1):68-77. PubMed ID: 8180514
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A randomized placebo-controlled trial of fluvastatin for prevention of restenosis after successful coronary balloon angioplasty; final results of the fluvastatin angiographic restenosis (FLARE) trial.
    Serruys PW; Foley DP; Jackson G; Bonnier H; Macaya C; Vrolix M; Branzi A; Shepherd J; Suryapranata H; de Feyter PJ; Melkert R; van Es GA; Pfister PJ
    Eur Heart J; 1999 Jan; 20(1):58-69. PubMed ID: 10075142
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Experimental and early clinical experience with reviparin-sodium for prevention of restenosis after percutaneous transluminal coronary angioplasty.
    Preisack MB; Karsch KR
    Blood Coagul Fibrinolysis; 1993 Dec; 4 Suppl 1():S55-8; discussion S59-60. PubMed ID: 8180331
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Fluvastatin for the prevention of restenosis after coronary balloon angioplasty: angiographic and methodological background of the fluvastatin angioplasty restenosis trial.
    Foley DP; Serruys PW
    Br J Clin Pract Suppl; 1996 Jan; 77A():40-53. PubMed ID: 8729590
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fluvastatin for the prevention of restenosis after coronary balloon angioplasty: angiographic and methodological background of the fluvastatin angioplasty restenosis trial.
    Foley DP; Serruys PW
    Br J Clin Pract Suppl; 1994 Dec; (77):39-50. PubMed ID: 19496272
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prevention of restenosis after coronary balloon angioplasty: rationale and design of the Fluvastatin Angioplasty Restenosis (FLARE) Trial. The FLARE Study Group.
    Foley DP; Bonnier H; Jackson G; Macaya C; Shepherd J; Vrolix M; Serruys PW
    Am J Cardiol; 1994 May; 73(14):50D-61D. PubMed ID: 8198025
    [TBL] [Abstract][Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.